• Register
  • Login
  • Bookmark this page!
Skip Navigation LinksHome Page    >    The common diseases affecting adults    >    The human genome project
 
 
Pregnancy links...
Health links...
Genetics links...
Medical links...
Autism links...
Other links...
 

The human genome project

More than in any other field, innovations in the field of genetics herald the beginning of a new era in medicine. Even now questions are asked about how these innovations will change our life and health, and the diagnosis, treatment, and moreover the prevention of disease. The completion of the project of decoding the human genome has enormous practical meaning for each and every one of us that is of far greater significance than man's historic first steps on the moon. The decoding of the genetic sequence, together with new technologies such as genetic chips, will enable the rapid, revolutionary development of drugs that can be tailored to each patient individually. How will these developments be integrated ethically and how do we expect to cope with the social and legal difficulties involved? Will these innovations result in an increase in the gap between the populations of the rich and the poor countries and between the rich and the poor in each society? It can be assumed that these questions, which are already being asked today, will gain momentum at a more rapid pace than previously thought.

The dramatic declaration of the completion of the decoding of the human genetic sequence has, as expected, caused great excitement throughout the world and has unleashed the potential of the human imagination with no little enthusiasm. While the President of the USA compares the project to man's first step on the moon, the media has been filled with a great many interviews and revelations about the moral dangers inherent in this discovery. The practical significance of the completion of the project and its actual relevance for each of us in general and the medical profession in particular has been talked about less.

The decoding of the genome has also been accompanied by significant technological progress, including the development of improved equipment, and the combination of these will enable advances to be made in the development of drugs for diseases currently considered incurable.

The decoding of the sequence reveals genetic variation between humans. Molecular genetic research is relatively young, having started only about 30 years ago with little information about the structure of the genetic material. Today, three decades later, amazing progress has been made, and we now know the full sequence of all the genetic material in man and in a large number of other animals.

The innovation is thus the deciphering of the sequence of our genetic material. People are similar to one another in 99.9% of their genetic sequences - the differences between them are caused by variations in the structure of only 0.1% of their genes, and this is the reason that some people have higher tendencies and some lower tendencies to contract various diseases, develop side effects to certain drugs, etc. Technological development has enabled us to understand the meaning of the millions of bases (represented by letters) in the genetic code that constitute the basis for each individual's tendency to contract certain diseases.

These important variations are currently being studied intensively, and this research is still in its infancy. With regard to medical applications, there are 3 main types of variations in the genetic material, as will be specified below.

The significance of genetic variation

"First degree variation" is present in a large proportion of the genetic material. There are widespread regions that separate genes from one another - these are called "junk DNA". They are repetitive sequences that are of research importance, but genetic differences in these regions have no medical significance. They are used for other purposes, such as paternity testing, identifying remains of victims, and for other forensic identification.

"Second degree variation" refers to genetic mutations that cause severe congenital diseases such as Tay Sachs disease and cystic fibrosis, where prenatal diagnosis is extremely important. People carrying this type of mutation are at risk of having an affected child if they marry a carrier of a mutation in the same gene.

Tests are already available today for identifying carriers of some severe genetic diseases, but the number of diseases for which this is possible is still limited. Considering that there are thousands of severe genetic diseases that we would like to be able to detect in the fetus and/or in the parents, it can be assumed that in the near future there will be a battery of tests for identifying the carrier status for severe genetic mutations. These will allow ascertainment of the parents' carrier status and enable fetal diagnosis by amniocentesis. Such a test battery will be affordable and quick, and will become a routine tool for gynecologists and geneticists.

"Third degree variation" is the most interesting type. The completion of the research into this type of variation is currently the ultimate goal of all physicians and patients because it is this that determines which common diseases each of us may develop, such as diabetes, hypertension various forms of cancer, cardiovascular disease, etc.

Genetic structure and common disease

We shall now focus on third degree variation. These differences are responsible for the predisposition of one individual to one particular disease and of another individual to another. Furthermore, they are also responsible for the degree of effectiveness of the person's response to medication. The fact that a particular treatment is effective in only 60% of patients, for example, is explained by variation in genetic structure, and this also accounts for the fact that different people taking the same drug have different side effects.

Now that the entire genetic sequence has been decoded, the major research currently underway is aimed at learning more about the genetic variations. An outcome of this will be the preparation of batteries for examining the millions of bases, mutations of which result in the development of common diseases. Within a decade or so, physicians will be able to advise their patients on the most suitable environments for them, and on what vitamins and minerals they should be taking in order to reduce their risks for becoming ill. They will be able to determine which follow-up tests are the most important, and, most interestingly of all, whether the person will develop an illness. The physician will also be able to prescribe the drug most suitable for the patient's genetic constitution in terms of both therapeutic efficacy and the absence of side effects. Essentially, these are the tasks that we shall be facing in the next ten years.

New beginnings in genetic technology

Alongside the decoding of the genetic sequence, there have also been highly significant technological advances. Today, "genetic chips" that allow the simultaneous examination of a very large number of genes have already been developed.

Apart from the identification of these genetic changes, the genetic chip also allows us to learn about and identify functional changes in each tissue. The genetic chip apparatus is relatively small. DNA segments that are part of the subject's genes are smeared onto a glass slide, and in the near future, it will be possible to examine a segment that is representative of all of a person's genes. Using such a chip, the expressed genes (active genes that are transcribed to RNA, which is later translated into protein) in a given tissue that is being tested will be identifiable. In this way, RNA may be taken from both diseased and healthy tissue, each stained with a different colored dye, and these poured onto a chip in order to obtain the profile of the differences in genetic activity between the two cells. By doing this it will be possible to see what is wrong with the abnormal cell, and once this has been defined, 100 different drugs may be tested to see which will lead to the restoration of the cell's normal activity.

Shortening the time for the development of drugs and adapting them for the patient

The combination of advanced technologies (such as the genetic chip) and the identification of the sequence of the genes have already allowed pharmaceutical companies to shorten significantly the time required to develop new drugs. Testing these can be carried out without delay, and in the near future it will be possible to determine their efficacy within weeks, without the need to experiment for years on animals and then on humans.

Concurrently, two very significant processes are taking place. The rate of development of new drugs is about to improve strikingly, while individual tailoring of drugs to each person on the basis of his genetic constitution will become feasible.

We should be aware that a certain time would have to elapse before we will feel that the new technology is safe. We are currently at a stage when we are still digesting all the developments that have taken place up to now. However, it is expected that within 10 - 20 years, this will be the conventional way of developing new drugs.

What else does the future hold?

Apart from the anticipated advances in the fields of genetic testing and clinical diagnosis, treatment and prevention of common, chronic illnesses, further achievements resulting from technological developments in genetics can be expected. With the advent of the genetic chip and the ability to identify all the differences and variations in the genetic activity of each tissue, researchers predict that in another two decades or so genetic diagnosis will be performed by monitoring serial blood samples. Each person will be able to undergo a blood test once every 3 months, and the activity of the RNA will be compared to that measured in the sample given 3 months earlier. Any change will indicate the existence of a clinical finding. Using this method, the physician will be able to diagnose some cases of cancer within a few weeks of the onset, unlike today when a cancerous mass is usually detected only after a number of years. This will be a highly significant achievement with regard to future therapy, both for cancer and also for other conditions.

It is predicted that in 30 years clinical studies will not be conducted on humans. Through computer imagery it will be possible to calculate and analyze the effect of each drug (even a new, untried one) on the health of a particular person whose genetic constitution is known, and to compare this with the effect of the material on a person with a different genetic constitution.

Another result of these developments is a predicted significant increase in the number of pregnancies resulting from in vitro (outside of the body) fertilization, since it will be possible to guarantee a healthier fetus without performing an excessive number of abortions. As the number of parameters tested in order to select the healthiest out of a number of zygotes created by in vitro fertilization increases, this type of fertilization will eventually be preferred medically to spontaneous pregnancy.

At the present time, the introduction of genes into a zygote is strictly forbidden because of the fear of causing unexpected developmental defects in the fetus. However, according to reports from leading world research centers, it appears that this will in the future be a safe procedure, and within 20 years such treatments will be approved for use and considered ethical.

The ability to use genetic treatments to cure genetic diseases will improve markedly. These are currently given only in special cases, but their use will undoubtedly increase.

It can be expected that the aging mechanism will be elucidated, and then, it can be assumed, treatment of the zygote for the purpose of extending life expectancy and possibly extending our "youth" will start to be carried out.

Alongside these developments, there will also be new ethical and legal problems that will constitute new challenges for the general public. Physicians will have to change their work methods since a considerable amount of their work will be in the genetic field. They will have to integrate into a world of medicine that will become even more mechanized than it is at present.

From the social and public viewpoints, it can be expected that anti-technological movements will be established. There will be considerable social transformations and the percentage of older people will increase significantly. The differences in the ability to obtain assistance from new technology will lead to large social gaps in each society and between different countries and continents. These are important issues that will require careful consideration by the appropriate people in modern society.
 
Haven't found what you're looking for? Search for it here:   
Comments (3)


Friday, February 20, 2015 11:56 PM
(1) Prince  says:


Essay

How do you know when you have written your best essay? Because I think I might have just done my best work. I had a small assignment on a topic that I actually enjoy so I took my time with the essay and now that I have read it, I don’t think I have ever written anything so beautiful.


Wednesday, March 11, 2015 3:22 AM
(2) CARLTON  says:


writing services

You have talked about so much that I believe I have become something of an expert on this. What might not be clear is if all these services have editors as well as writers. It would be a loss otherwise.


Thursday, June 11, 2015 11:35 PM
(3) free steam codes  says:


game fun

here is the official link that can generate free online codes of steam wallet for you at here.





Leave a Comment
Name
Email (will not be published)
Website (optional)
Subject
Your Comment

Line and paragraph breaks are automatic.

Please type the characters you see in the picture:


All content Copyright © 2009-2011, Genetics of Pregnancy Encyclopedia Corporation. All rights reserved.